157 related articles for article (PubMed ID: 18648005)
1. Modeling chromosomal translocations using conditional alleles to recapitulate initiating events in human leukemias.
Lobato MN; Metzler M; Drynan L; Forster A; Pannell R; Rabbitts TH
J Natl Cancer Inst Monogr; 2008; (39):58-63. PubMed ID: 18648005
[TBL] [Abstract][Full Text] [Related]
2. Mll fusions generated by Cre-loxP-mediated de novo translocations can induce lineage reassignment in tumorigenesis.
Drynan LF; Pannell R; Forster A; Chan NM; Cano F; Daser A; Rabbitts TH
EMBO J; 2005 Sep; 24(17):3136-46. PubMed ID: 16096649
[TBL] [Abstract][Full Text] [Related]
3. Leukaemia lineage specification caused by cell-specific Mll-Enl translocations.
Cano F; Drynan LF; Pannell R; Rabbitts TH
Oncogene; 2008 Mar; 27(13):1945-50. PubMed ID: 17906700
[TBL] [Abstract][Full Text] [Related]
4. MLL fusions: pathways to leukemia.
Liu H; Cheng EH; Hsieh JJ
Cancer Biol Ther; 2009 Jul; 8(13):1204-11. PubMed ID: 19729989
[TBL] [Abstract][Full Text] [Related]
5. Circular RNAs drive oncogenic chromosomal translocations within the MLL recombinome in leukemia.
Conn VM; Gabryelska M; Toubia J; Kirk K; Gantley L; Powell JA; Cildir G; Marri S; Liu R; Stringer BW; Townley S; Webb ST; Lin H; Samaraweera SE; Bailey S; Moore AS; Maybury M; Liu D; Colella AD; Chataway T; Wallington-Gates CT; Walters L; Sibbons J; Selth LA; Tergaonkar V; D'Andrea RJ; Pitson SM; Goodall GJ; Conn SJ
Cancer Cell; 2023 Jul; 41(7):1309-1326.e10. PubMed ID: 37295428
[TBL] [Abstract][Full Text] [Related]
6. Complex MLL rearrangements in t(4;11) leukemia patients with absent AF4.MLL fusion allele.
Kowarz E; Burmeister T; Lo Nigro L; Jansen MW; Delabesse E; Klingebiel T; Dingermann T; Meyer C; Marschalek R
Leukemia; 2007 Jun; 21(6):1232-8. PubMed ID: 17410185
[TBL] [Abstract][Full Text] [Related]
7. MLL-ENL-mediated leukemia initiation at the interface of lymphoid commitment.
Ugale A; Säwén P; Dudenhöffer-Pfeifer M; Wahlestedt M; Norddahl GL; Bryder D
Oncogene; 2017 Jun; 36(22):3207-3212. PubMed ID: 28068328
[TBL] [Abstract][Full Text] [Related]
8. CRISPR-Cas9-induced t(11;19)/MLL-ENL translocations initiate leukemia in human hematopoietic progenitor cells
Reimer J; Knöß S; Labuhn M; Charpentier EM; Göhring G; Schlegelberger B; Klusmann JH; Heckl D
Haematologica; 2017 Sep; 102(9):1558-1566. PubMed ID: 28572162
[TBL] [Abstract][Full Text] [Related]
9. Systematic Classification of Mixed-Lineage Leukemia Fusion Partners Predicts Additional Cancer Pathways.
Marschalek R
Ann Lab Med; 2016 Mar; 36(2):85-100. PubMed ID: 26709255
[TBL] [Abstract][Full Text] [Related]
10. Learning from mouse models of MLL fusion gene-driven acute leukemia.
Schwaller J
Biochim Biophys Acta Gene Regul Mech; 2020 Aug; 1863(8):194550. PubMed ID: 32320749
[TBL] [Abstract][Full Text] [Related]
11. Chromosomal translocation engineering to recapitulate primary events of human cancer.
Forster A; Pannell R; Drynan L; Cano F; Chan N; Codrington R; Daser A; Lobato N; Metzler M; Nam CH; Rodriguez S; Tanaka T; Rabbitts T
Cold Spring Harb Symp Quant Biol; 2005; 70():275-82. PubMed ID: 16869763
[TBL] [Abstract][Full Text] [Related]
12. Bioflavonoids promote stable translocations between MLL-AF9 breakpoint cluster regions independent of normal chromosomal context: Model system to screen environmental risks.
Bariar B; Vestal CG; Deem B; Goodenow D; Ughetta M; Engledove RW; Sahyouni M; Richardson C
Environ Mol Mutagen; 2019 Mar; 60(2):154-167. PubMed ID: 30387535
[TBL] [Abstract][Full Text] [Related]
13. Acute leukemias of different lineages have similar MLL gene fusions encoding related chimeric proteins resulting from chromosomal translocation.
Corral J; Forster A; Thompson S; Lampert F; Kaneko Y; Slater R; Kroes WG; van der Schoot CE; Ludwig WD; Karpas A
Proc Natl Acad Sci U S A; 1993 Sep; 90(18):8538-42. PubMed ID: 8378328
[TBL] [Abstract][Full Text] [Related]
14. MLL gene fusions in human leukaemias: in vivo modelling to recapitulate these primary tumourigenic events.
Rodriguez-Perales S; Cano F; Lobato MN; Rabbitts TH
Int J Hematol; 2008 Jan; 87(1):3-9. PubMed ID: 18224407
[TBL] [Abstract][Full Text] [Related]
15. Development of embryonic and adult leukemia mouse models driven by MLL-ENL translocation.
Sinha R; Porcheri C; d'Altri T; González J; Ruiz-Herguido C; Rabbitts T; Espinosa L; Bigas A
Exp Hematol; 2020 May; 85():13-19. PubMed ID: 32437911
[TBL] [Abstract][Full Text] [Related]
16. Malignant hematopoietic cell lines: in vitro models for the study of MLL gene alterations.
Drexler HG; Quentmeier H; MacLeod RA
Leukemia; 2004 Feb; 18(2):227-32. PubMed ID: 14671638
[TBL] [Abstract][Full Text] [Related]
17. Engineering de novo reciprocal chromosomal translocations associated with Mll to replicate primary events of human cancer.
Forster A; Pannell R; Drynan LF; McCormack M; Collins EC; Daser A; Rabbitts TH
Cancer Cell; 2003 May; 3(5):449-58. PubMed ID: 12781363
[TBL] [Abstract][Full Text] [Related]
18.
Schneidawind C; Jeong J; Schneidawind D; Kim IS; Duque-Afonso J; Wong SHK; Iwasaki M; Breese EH; Zehnder JL; Porteus M; Cleary ML
Blood Adv; 2018 Apr; 2(8):832-845. PubMed ID: 29650777
[TBL] [Abstract][Full Text] [Related]
19. Preclinical modeling of cytosine arabinoside response in Mll-Enl translocator mouse leukemias.
Cano F; Pannel R; Follows GA; Rabbitts TH
Mol Cancer Ther; 2008 Mar; 7(3):730-5. PubMed ID: 18347158
[TBL] [Abstract][Full Text] [Related]
20. The invertor knock-in conditional chromosomal translocation mimic.
Forster A; Pannell R; Drynan LF; Codrington R; Daser A; Metzler M; Lobato MN; Rabbitts TH
Nat Methods; 2005 Jan; 2(1):27-30. PubMed ID: 15782166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
